by | Aug 16, 2017 | Uncategorized
Author: Gonçalves A / Source: National Institutes of Health Abstract PURPOSE OF REVIEW: The purpose of the review is to summarize the data regarding PD-L1 expression in breast cancer and the results of first clinical trials with PD-1 or PD-L1 inhibitors in... 
by The Tutu Team | Apr 5, 2017 | Uncategorized
Author: Laura Panjwani / Source: Research & Development Patients with triple-negative breast cancer (TNBC) — a subtype which accounts for 10 to 20% of all breast cancers— have very few treatment options. Targeted therapies, which are used to treat many... by The Tutu Team | Oct 18, 2016 | Uncategorized
Beating Breast Cancer with Innovation by Dr. Ashok K. Vaid Breast Cancer: these words conjure up deep dread. The moment they are uttered, the world collapses for patients and family members, and the intense emotional and physical toll begins. Breast cancer is the most... 